Contact
Marie Selbiani
Email
+32 (0)490 08 31 56
iTeos Therapeutics is a publicly-traded (NASDAQ: ITOS), clinical-stage biopharmaceutical company dedicated to extending and improving the lives of patients with cancer by designing and developing next generation immunotherapies.
Based in Gosselies, Belgium and Watertown, MA, iTeos Therapeutics was founded out of the Ludwig Institute for Cancer Research (LICR) and the de Duve Institute (UClouvain) in 2011.
In March 2020, the Company completed a $125 million Series B2 financing, and in July 2020, we completed our IPO, raising over $230 million of gross proceeds. In June 2021, the Company entered into a transformative $2.145 billion co-development and co-commercialization agreement with GSK for EOS-448, the Company’s anti-TIGIT monoclonal antibody. As a well-capitalized biotech company, we are positioned to continue to develop our clinical pipeline and maintain our investments in our discovery research team to leverage our innovative science to improve the lives of patients with cancer.
For more information, please visit www.iteostherapeutics.com.
iTeos Therapeutics is now a world-class actor in the sector. To carry on its growth and reinforce its team, iTeos Therapeutics is looking for a Lab Technician.
iTeos Therapeutics is seeking a highly motivated and skilled Lab Technician to join the In Vivo Biology group in our Research and Development Department. The successful candidate will be responsible for supporting daily activities at the animal facility, including maintenance of facility installations, colony management, animal inoculation, treatment, monitoring and sample collections, as well as maintaining sanitary vigilance and control of stock and supplies.
Your main responsibilities are:
Your application and related information will remain strictly confidential.